Horsham, PA (Vocus) October 8, 2008
The Drug Information Association (DIA) will host the 6th Canadian Annual Meeting (November 5-7; Ottawa, Ontario, Canada) to discuss a number of important issues facing Health Canada, the pharmaceutical industry, health academia, and the health care system.
As the universally respected forum for quality information exchange leading to better medicines that enhance health and well-being, DIA, along with members of the Canadian pharmaceutical industry, are joining forces to promote safe and appropriate medication use among Canadians.
To this end, the 6th Canadian Annual Meeting will include parallel tracks focusing on:
- Risk Management planning
- Challenges in evidence generation and uptake in the real-world environment
- Pharmacovigilance planning
- Medical risk communications
- Progressive drug development
- Scientific and regulatory challenges of drug/Device combination products
- Quality-by-design continuous improvement
- International regulatory cooperation
- eSubmissions/Document management
- Natural Health Products
More than 30 exhibiting companies will be on hand to showcase their products and services.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.
Joe.Krasowski @ diahome.org
# # #